Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Go back to Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.11 +2.76 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.80 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 368,100 | |||||
